Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome

NCT06963840 is registered in ClinicalTrials.gov with Wellizen Australia as lead sponsor.

NCT NCT06963840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06963840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome
Lead sponsor
Wellizen Australia
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 9, 2025
Completion date
August 31, 2025
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polycystic ovarian syndrome (pcos)